Innoviva (INVA) Other Working Capital Changes (2010 - 2026)
Innoviva posted quarterly Other Working Capital Changes of $8.4 million for Q1 2026, up 6845.97% year-on-year from $120429.6 in Q1 2025, and up 836400.0% on a QoQ basis from $1000.0 in Q4 2025.
Innoviva (INVA) has 17 years of Other Working Capital Changes data on file, last reported at $8.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 6845.97% year-over-year to $8.4 million; the trailing twelve-month figure through Mar 2026 stood at $16.4 million (up 1578.93% YoY), and the FY2025 full-year result was $1000.0, up 100.66% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $8.4 million, up from $1000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $12.4 million in Q3 2025 and bottomed at -$14.8 million in Q3 2023.
- The 5-year median for Other Working Capital Changes is -$61500.0 (2025), against an average of $326571.4.
- The widest annual swing landed in 2025, when Other Working Capital Changes tumbled 2151.66%; it then soared 6845.97% in 2026.
- A 5-year view of Other Working Capital Changes shows it stood at $2.9 million in 2022, then sank by 605.8% to -$14.8 million in 2023, then soared by 96.22% to -$560000.0 in 2024, then surged by 100.18% to $1000.0 in 2025, then surged by 836400.0% to $8.4 million in 2026.
- The last three Other Working Capital Changes figures came in at $8.4 million (Q1 2026), $1000.0 (Q4 2025), and $12.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.37 Mn |
| Mar 31, 2026 | 8.37 Mn |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 12.45 Mn |
| Sep 30, 2025 | 12.45 Mn |
| Jun 30, 2025 | -4.33 Mn |
| Jun 30, 2025 | -4.33 Mn |
| Mar 31, 2025 | -124,000.00 |
| Mar 31, 2025 | -124,000.00 |
| Sep 30, 2024 | -560,000.00 |
| Sep 30, 2024 | -560,000.00 |
| Jun 30, 2024 | 211,000.00 |
| Jun 30, 2024 | 211,000.00 |
| Mar 31, 2024 | -633,000.00 |
| Mar 31, 2024 | -633,000.00 |
| Sep 30, 2023 | -14.83 Mn |
| Sep 30, 2023 | -14.83 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Mar 31, 2023 | -5.44 Mn |
| Mar 31, 2023 | -5.44 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 1.28 Mn |
| Jun 30, 2022 | 1.28 Mn |
| Mar 31, 2022 | -1.35 Mn |
| Mar 31, 2022 | -1.35 Mn |
| Sep 30, 2021 | -328,000.00 |
| Sep 30, 2021 | -328,000.00 |
| Jun 30, 2021 | -335,000.00 |
| Jun 30, 2021 | -335,000.00 |
| Mar 31, 2021 | -243,000.00 |
| Mar 31, 2021 | -243,000.00 |
| Dec 31, 2020 | 264,000.00 |
| Dec 31, 2020 | 264,000.00 |
| Sep 30, 2020 | 53,000.00 |
| Sep 30, 2020 | 53,000.00 |
| Jun 30, 2020 | -177,000.00 |
| Jun 30, 2020 | -177,000.00 |
| Mar 31, 2020 | -140,000.00 |
| Mar 31, 2020 | -140,000.00 |
| Sep 30, 2019 | 264,000.00 |
| Sep 30, 2019 | 264,000.00 |
| Jun 30, 2019 | -243,000.00 |
| Jun 30, 2019 | -243,000.00 |
| Mar 31, 2019 | -147,000.00 |
| Mar 31, 2019 | -147,000.00 |
| Dec 31, 2018 | -4,000.00 |
| Dec 31, 2018 | -4,000.00 |
| Jun 30, 2018 | 4,000.00 |
| Jun 30, 2018 | 4,000.00 |
| Dec 31, 2017 | 651,000.00 |
| Dec 31, 2017 | 651,000.00 |
| Sep 30, 2017 | -221,000.00 |
| Sep 30, 2017 | -221,000.00 |
| Jun 30, 2017 | -221,000.00 |
| Jun 30, 2017 | -221,000.00 |
| Mar 31, 2017 | -221,000.00 |
| Mar 31, 2017 | -221,000.00 |
| Dec 31, 2016 | 232,000.00 |
| Dec 31, 2016 | 232,000.00 |
| Sep 30, 2016 | -320,000.00 |
| Sep 30, 2016 | -320,000.00 |
| Jun 30, 2016 | 42,000.00 |
| Jun 30, 2016 | 42,000.00 |
| Mar 31, 2016 | -2,000.00 |
| Mar 31, 2016 | -2,000.00 |
| Dec 31, 2015 | -2,000.00 |
| Dec 31, 2015 | -2,000.00 |
| Sep 30, 2015 | -2,000.00 |
| Sep 30, 2015 | -2,000.00 |
| Jun 30, 2015 | 13,000.00 |
| Jun 30, 2015 | 13,000.00 |
| Mar 31, 2015 | -16,000.00 |
| Mar 31, 2015 | -16,000.00 |
| Dec 31, 2014 | 3.25 Mn |
| Dec 31, 2014 | 3.25 Mn |
| Sep 30, 2014 | -3.09 Mn |
| Sep 30, 2014 | -3.09 Mn |
| Jun 30, 2014 | -821,000.00 |
| Jun 30, 2014 | -821,000.00 |
| Mar 31, 2014 | 998,000.00 |
| Mar 31, 2014 | 998,000.00 |
| Dec 31, 2013 | -299,000.00 |
| Dec 31, 2013 | -299,000.00 |
| Jun 30, 2013 | -4.95 Mn |
| Jun 30, 2013 | -4.95 Mn |
| Mar 31, 2013 | 4.95 Mn |
| Mar 31, 2013 | 4.95 Mn |
| Dec 31, 2012 | -128,000.00 |
| Dec 31, 2012 | -128,000.00 |
| Sep 30, 2012 | -129.85 Mn |
| Sep 30, 2012 | -129.85 Mn |
| Jun 30, 2012 | -502,000.00 |
| Jun 30, 2012 | -502,000.00 |
| Mar 31, 2012 | 375,000.00 |
| Mar 31, 2012 | 375,000.00 |
| Dec 31, 2011 | -16.65 Mn |
| Dec 31, 2011 | -16.65 Mn |
| Sep 30, 2011 | -266,000.00 |
| Sep 30, 2011 | -266,000.00 |
| Jun 30, 2011 | -1.64 Mn |
| Jun 30, 2011 | -1.64 Mn |
| Mar 31, 2011 | -73,000.00 |
| Mar 31, 2011 | -73,000.00 |
| Dec 31, 2010 | 15.45 Mn |
| Dec 31, 2010 | 15.45 Mn |
| Sep 30, 2010 | -14.74 Mn |
| Sep 30, 2010 | -14.74 Mn |